Advisor Group Holdings, Inc. Relmada Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 27 shares of RLMD stock, worth $11. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 27
-0.0%
Holding current value
$11
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RLMD
# of Institutions
80Shares Held
12.3MCall Options Held
229KPut Options Held
138K-
Franklin Resources Inc San Mateo, CA1.3MShares$533,8810.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$515,2490.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.19MShares$486,4450.01% of portfolio
-
Parsons Capital Management Inc1MShares$411,1040.21% of portfolio
-
Palo Alto Investors LP Palo Alto, CA732KShares$300,2840.33% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $11.7M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...